About StratiCELL
StratiCELL is a Healthcare company based in Gembloux (Belgium) founded in 2005, and was acquired by Plant Advanced Technologies in January 2016. Integrated solution provider for in vitro testing of skin care and dermatology products. The company has 11 employees. StratiCELL offers products and services including Cosmetic Testing, Dermatology Testing, and MicroBIOS Platform. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Analytical Testing.
Company details
StratiCell was founded in 2005 in Gembloux, Belgium, where in vitro testing services for dermatological actives and products are conducted following topical or systemic applications. Testing is performed on monolayer cell cultures, reconstituted human epithelia, and human skin biopsies within the biotechnology sector. The company was acquired in January 2016 by Plant Advanced Technologies for an undisclosed amount.
- Headquarters Gembloux, Belgium
- Employees 11
- Stage Acquired
- SectorsHealthcare
- Website straticell.com
- Social LinkedIn
- Acquired by Plant Advanced Technologies (Jan 2016)
- Legal Name Straticell
- Net Profit$45.75 K (USD)-80as on Dec 31, 2022
- EBITDA$370.62 K (USD)413as on Dec 31, 2021
- Latest Funding Round$440.38K (USD), Grant
Oct 2020
- InvestorsPlant Advanced Technologies
& 1 more
- Employee Count11
- Acquired byPlant Advanced Technologies
(Jan 2016)
Products & Services of StratiCELL
StratiCELL offers a comprehensive portfolio of products and services, including Cosmetic Testing, Dermatology Testing, and MicroBIOS Platform.
In vitro testing for cosmetic claims and ingredient efficacy
Screening for drug effects on skin biology and conditions
Platform for testing impacts on skin microbiome and infections
Funding Insights of StratiCELL
- Total Rounds 1
- Last Round Grant β $440,382
- First Round $440,382
(Oct 2020)
- Investors Count 1
All 1 funding rounds of StratiCELL with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | $440,382 | Grant | β | β |
2 investors in total: 2 institutional.
Investors in StratiCELL
StratiCELL has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Plant Advanced Technologies and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Plant biotechnology is applied to cosmetic and pharmaceutical uses. | 2005 | plantadvanced.com | Nancy, France |
Investor details for StratiCELL
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of StratiCELL
3 dated milestones of StratiCELL across 15 years, from founding to its latest funding, stage changes and deals.
- Founded StratiCELL is founded.
- Exit Acquired by Plant Advanced Technologies.
- Funding First funding round of $440K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about StratiCELL
StratiCELL was founded in 2005 and raised its 1st funding round 15 years after it was founded.
StratiCELL is headquartered in Gembloux, Belgium. It is registered at Gembloux, Namur, Belgium.
StratiCELL has 11 employees.
StratiCell was founded in 2005 in Gembloux, Belgium, where in vitro testing services for dermatological actives and products are conducted following topical or systemic applications. Testing is performed on monolayer cell cultures, reconstituted human epithelia, and human skin biopsies within the biotechnology sector. The company was acquired in January 2016 by Plant Advanced Technologies for an undisclosed amount.
StratiCELL offers Cosmetic Testing, Dermatology Testing, and MicroBIOS Platform.
StratiCELL has 2 investors. Key investors include Plant Advanced Technologies, and European Union.
StratiCELL operates through Straticell.
Yes. StratiCELL was acquired by Plant Advanced Technologies in January 2016.
